Grants and contributions disclosures

All AbbVie grant requests originating from the United States and Puerto Rico are managed by a centralized grant department and more information is available at Support from the AbbVie Foundation, a nonprofit, 501(c)(3), is reported in an annual Internal Revenue Service 990-PF filing. This information is available at

Additional grants and contributions disclosures for support paid separately by Pharmacyclics, an AbbVie company is available at

The list of AbbVie’s grants and contributions are provided in the annual reports below.

AbbVie’s reports reflect educational grants, patient support, corporate sponsorships, charitable donations, as well as fellowships and scholarships. The reports include individual direct payments of more than $200 from AbbVie’s US and Puerto Rico businesses. The reports may be updated periodically to reflect new data.    

Annual Reports


AbbVie officially became a company January 1, 2013. In May 2020, AbbVie completed the acquisition of Allergan and began operating as a combined company.